Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nitric oxide (NO) production pathway refers to the biological processes by which nitric oxide, a gaseous signaling molecule, is synthesized and regulated in living organisms. Key enzymes are nitric oxide synthases (NOS), which catalyze the conversion of L-arginine to L-citrulline with the release of NO. Regulation occurs at multiple levels including enzyme expression, calcium/calmodulin binding, and competition for substrates. Dysregulation contributes to pathologies such as hypertension, septic shock, stroke, and neurodegeneration.
Varied depending on target. NOS inhibitors block NO synthesis, NO donors increase NO levels.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric Oxide Production Pathway (NO Pathway).